Approval · Notice of Compliance 28064 · 2022
ZADITEN: Notice of Compliance 28064
Issued May 2, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28064
- Date
- May 2, 2022
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update the API name on labels Update the bottle labels to align with rebrand
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZADITEN | Not yet assigned | — |
Medicinal ingredients
- KETOTIFEN FUMARATE 1 MG per TAB